Evidence-based clinical practice guidelines for peptic ulcer disease 2015
- PMID: 26879862
- DOI: 10.1007/s00535-016-1166-4
Evidence-based clinical practice guidelines for peptic ulcer disease 2015
Abstract
The Japanese Society of Gastroenterology (JSGE) revised the evidence-based clinical practice guidelines for peptic ulcer disease in 2014 and has created an English version. The revised guidelines consist of seven items: bleeding gastric and duodenal ulcers, Helicobacter pylori (H. pylori) eradication therapy, non-eradication therapy, drug-induced ulcer, non-H. pylori, non-nonsteroidal anti-inflammatory drug (NSAID) ulcer, surgical treatment, and conservative therapy for perforation and stenosis. Ninety clinical questions (CQs) were developed, and a literature search was performed for the CQs using the Medline, Cochrane, and Igaku Chuo Zasshi databases between 1983 and June 2012. The guideline was developed using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) system. Therapy is initially provided for ulcer complications. Perforation or stenosis is treated with surgery or conservatively. Ulcer bleeding is first treated by endoscopic hemostasis. If it fails, surgery or interventional radiology is chosen. Second, medical therapy is provided. In cases of NSAID-related ulcers, use of NSAIDs is stopped, and anti-ulcer therapy is provided. If NSAID use must continue, the ulcer is treated with a proton pump inhibitor (PPI) or prostaglandin analog. In cases with no NSAID use, H. pylori-positive patients receive eradication and anti-ulcer therapy. If first-line eradication therapy fails, second-line therapy is given. In cases of non-H. pylori, non-NSAID ulcers or H. pylori-positive patients with no indication for eradication therapy, non-eradication therapy is provided. The first choice is PPI therapy, and the second choice is histamine 2-receptor antagonist therapy. After initial therapy, maintenance therapy is provided to prevent ulcer relapse.
Keywords: Cyclooxygenase-2; Duodenal ulcer; Gastric ulcer; Helicobacter pylori eradication; Low-dose aspirin; Nonsteroidal anti-inflammatory drug; Peptic ulcer; Stomach ulcer.
Similar articles
-
Systematic reviews of the clinical effectiveness and cost-effectiveness of proton pump inhibitors in acute upper gastrointestinal bleeding.Health Technol Assess. 2007 Dec;11(51):iii-iv, 1-164. doi: 10.3310/hta11510. Health Technol Assess. 2007. PMID: 18021578 Review.
-
Evidence-based clinical practice guidelines for peptic ulcer disease 2020.J Gastroenterol. 2021 Apr;56(4):303-322. doi: 10.1007/s00535-021-01769-0. Epub 2021 Feb 23. J Gastroenterol. 2021. PMID: 33620586 Free PMC article.
-
Peptic ulcer disease today.Nat Clin Pract Gastroenterol Hepatol. 2006 Feb;3(2):80-9. doi: 10.1038/ncpgasthep0393. Nat Clin Pract Gastroenterol Hepatol. 2006. PMID: 16456574 Review.
-
Critical issues in the pathophysiology and management of peptic ulcer disease.Eur J Gastroenterol Hepatol. 1995 Jul;7(7):685-99. Eur J Gastroenterol Hepatol. 1995. PMID: 8590166 Review.
-
[Recommendation for the prevention and treatment of non-steroidal anti-inflammatory drug-induced gastrointestinal ulcers and its complications].Zhonghua Nei Ke Za Zhi. 2017 Jan 1;56(1):81-85. doi: 10.3760/cma.j.issn.0578-1426.2017.01.021. Zhonghua Nei Ke Za Zhi. 2017. PMID: 28056333 Chinese.
Cited by
-
Continuous improvement on the rationality of prophylactic injectable PPIs usage by a clinical pharmacist-led guidance team at a Chinese tertiary teaching hospital.J Int Med Res. 2020 Oct;48(10):300060520954729. doi: 10.1177/0300060520954729. J Int Med Res. 2020. PMID: 33045898 Free PMC article.
-
Gastroprotective Effect of Enteral Nutrition Formula in Mice Injected Subcutaneously with Indomethacin.Nutrients. 2021 Sep 21;13(9):3297. doi: 10.3390/nu13093297. Nutrients. 2021. PMID: 34579173 Free PMC article.
-
Daily Usage of Proton Pump Inhibitors May Reduce the Severity of Critical Upper Gastrointestinal Bleeding in Elderly Patients.Gastroenterol Res Pract. 2020 Aug 6;2020:7168621. doi: 10.1155/2020/7168621. eCollection 2020. Gastroenterol Res Pract. 2020. PMID: 32831828 Free PMC article.
-
Potent Potassium-competitive Acid Blockers: A New Era for the Treatment of Acid-related Diseases.J Neurogastroenterol Motil. 2018 Jul 30;24(3):334-344. doi: 10.5056/jnm18029. J Neurogastroenterol Motil. 2018. PMID: 29739175 Free PMC article. Review.
-
Severity of gastric mucosal atrophy affects the healing speed of post-endoscopic submucosal dissection ulcers.World J Gastrointest Endosc. 2018 May 16;10(5):83-92. doi: 10.4253/wjge.v10.i5.83. World J Gastrointest Endosc. 2018. PMID: 29774087 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials